What is AEON's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 0.01B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for AEON?

P/E (TTM) is n/a and 52-week range is $0.18 to $1.45 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s AEON figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for AEON?

The company profile lists net income (TTM) near $-133M, EPS (TTM) near $-3.58 when available from the market-data feed. Figures are informational and may lag live markets.

Where is AEON Biopharma Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in Newport Beach, California, US, 37.2M shares outstanding, ISIN US00775E1029 when available from company profile and filing metadata.

AEON Biopharma Inc

$AEON

N/A

IR Run Scenarios

$0.28

-10.97%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is headquartered in Newport Beach, California and currently employs 6 full-time employees. The company went IPO on 2021-10-08. The firm is focused on developing botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions. The biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a molecular weight of 900 kDa. Its initial development programs for ABP-450 are focused on migraine, cervical dystonia and gastroparesis. Migraine is a neurological condition characterized by recurrent episodes of headaches. The firm is developing ABP-450 for the preventative treatment of migraine, which is inclusive of both chronic migraine and episodic migraine. Cervical dystonia is a neurological condition characterized by involuntary muscle contractions of the neck which may present as spasms, contractions or abnormal posture. Gastroparesis is a gastrointestinal disorder characterized by the slowing or stoppage of movement of food and liquid from the stomach to the small intestine.

Employees

Website

www.aeonbiopharma.com/

IPO

2021-10-08

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)